Bayer: Will the Pillars Crumble?

Bayer's voluntary withdrawal of cholesterol drug Baycol increased the pressure on the German chemicals conglomerate to sell its pharmaceuticals business. Bayer's decision to hold on to it--albeit less tightly--reflects both strategic and cultural concerns.